| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_143ac4fbe1e063c6a828a96cfffc34d5 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A47L1-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A47L1-13 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14 |
| filingDate |
2003-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_493d5af4827d2772631ea54969e2b288
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3bc8632ee3bacd37fec3b28489ba1b12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_adfa8f3bd230dd2b9ca6108c2a993c0e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_384b98d4fe10424f0b843020dd8bb770 |
| publicationDate |
2004-09-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20040077244-A |
| titleOfInvention |
Controlled release pellets for oral and it's manufacturing process |
| abstract |
The present invention relates to a single pellet controlled release formulation which satisfies both the initial blood concentration of the drug and the maintenance of a long continuous blood concentration in one pellet. The single pellet controlled release formulation according to the present invention is inert spherical nucleus and drug. It consists of a fast-release drug layer containing a drug and a sustained-release drug layer containing a drug, wherein the fast-release drug layer is composed of a mixture of hydrophilic polymer hydroxypropyl methylcellulose (Hydroxypropylmethylcellulose) and a hydrophilic polymer PEG 6000, The drug release layer is characterized in that the hydrophobic polymer ethylcellulose (Ethylcellulose) and the hydrophilic polymer PEG 6000 is mixed to control the release of the drug. Pellet-type controlled release formulation according to the present invention can be manufactured with a uniform drug content and easy to take oral controlled release formulations to increase the pharmacological efficacy in the field of hypertension, diabetes, circulatory diseases, etc. You can. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012141502-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011108826-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101143997-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20140104341-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100636546-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100806541-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015099365-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100771426-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015099364-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101310099-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012141502-A3 |
| priorityDate |
2003-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |